Malassezia growth on peritumoral skin after routine methyl-5-aminolevulinate photodynamic therapy for actinic keratosis and nonmelanoma skin cancer.
نویسندگان
چکیده
Malassezia (Pityrosporum) species are lipophilic yeasts that are recognized as commensals of the skin of warm-blooded vertebrates. Aryl-hydrocarbon receptor (AhR) ligands produced by Malassezia species have been implicated in carcinogenesis, suggesting that this yeast may contribute to the development of skin cancer, particularly basal cell carcinoma (BCC). This hypothesis suggests that skin cancer treatments that combine antitumoral and antimicrobial effects may be particularly effective. We investigated the effect of routine methylaminolevulinate photodynamic therapy (MAL-PDT) on Malassezia species present in the flora of peritumoral skin. The participants were patients with non-melanoma skin cancer who were treated with MAL-PDT (Metvix® in combination with Aktilite® red light illumination, 37 J/cm) in the Dermatology Department of the Hospital General San Jorge (Huesca, Spain) between September and November 2012. Swab samples were taken from a 2-cm area of skin within 1 cm of the lesion before and after MAL-PDT. Control swab samples were taken from an adjacent area of healthy skin before and after exposure to red light illumination only. The skin was not prepared before swabbing. Swabs were then used to immediately inoculate the entire surface of individual Dixon plates, which were incubated at 35 ◦C. Malassezia species were identified by micromorphology (morphological microscopy), cultural characteristics (effect of temperature, subculture on Sabouraud agar, growth and appearance on Leeming and Notman agar, Dixon modified media, CHROMagar, and Tween agar), biochemical characteristics (catalase production, bile esculin test), and the assimilation profile when grown on Tween agar. All data are presented as the mean and standard deviation (SD). Differences between groups were evaluated using the Mann--Whitney U test, Kruskal--Wallis test, and Wilcoxon matched-pairs signed ranked test, assuming a confidence level of 95% (i.e., P < .05). Analyses were performed using IBM SPSS software (Version 19.0). The study was approved by the regional ethics committee for clinical research. Thirty patients (19 men and 11 women) participated in the study. Of these, 19 (63.3%) were treated for actinic keratosis, 10 (33.4%) for BCC, and 1 (3.3%) for Bowen disease. Lesions were most commonly located on the forehead (26.7%) and scalp (23.3%), followed by the nose (16.7%), back (10%), cheek (6.7%), neck (6.7%), chest (6.7%), and ear (3.3%). In 13 patients Malassezia species were detected in both the peritumoral and control areas before treatment. The most commonly found species was Malassezia globosa (10 patients), either alone or in combination with other species, followed by Malassezia sympodialis (3 patients). Treatment resulted in a decrease in the number of colonies in the peritumoral and control areas in 10 and 8 patients, respectively. The mean number of colonies observed before treatment was 46.00 (50.67) in the peritumoral area and 63.38 (119.44) in the control area. MAL-PDT resulted in a significant decrease in the number of colonies in the peritumoral area (20.46[33.94], P = .023); this effect was not observed in the control area after exposure to red light illumination (40.69[61.49], P = .22) (Fig. 1). The decrease in the mean number of colonies induced by MAL-PDT was significantly greater in patients that were positive for both M. globosa and M. sympodialis (76[15.06]) than in those with M. globosa alone (12.36[20.54]) or with other Malassezia species (P = .007). We found no association between the mean number of Malassezia colonies and patient gender (P = .70), tumor type (P = .95), or tumor location (P = .21). Our results demonstrate that routine MAL-PDT attenuates the growth of Malassezia species on peritumoral skin. This observation is in line with previous reports describing the effectiveness of MAL-PDT in pityriasis versicolor, recalcitrant Malassezia folliculitis, and onychomycosis. The inhibitory effect of MAL-PDT on M. globosa was greater than that observed for M. sympodialis, suggesting that sensitivity to MAL-PDT varies among Malassezia species. In line with
منابع مشابه
Photodynamic Therapy in the Management of Nonmelanoma Skin Cancers
Photodynamic therapy involves the use of light to activate a photosensitizer, localized in the diseased skin, resulting in the formation of cytotoxic reactive oxygen species. Topical photodynamic therapy (PDT) is used to treat nonmelanoma skin cancers, such as actinic keratoses, Bowen's disease, and basal cell carcinoma, superficial as well as nodular. This article presents up-to-date, practica...
متن کاملPhotodynamic Therapy Activated by Intense Pulsed Light in the Treatment of Nonmelanoma Skin Cancer
Photodynamic therapy (PDT) with topical 5-aminolevulinic acid (ALA) or methyl aminolevulinate (MAL) has proven to be a highly effective conservative method for the treatment of actinic keratosis (AK), Bowen's disease (BD), and superficial basal cell carcinoma (sBCC). PDT is traditionally performed in association with broad-spectrum continuous-wave light sources, such as red or blue light. Recen...
متن کاملPhotodynamic therapy for nonmelanoma skin cancer.
Photodynamic therapy (PDT) involves the administration of a photosensitizing drug and its subsequent activation by light at wavelengths matching the absorption spectrum of the photosensitizer. Because the skin is readily accessible to light-based therapies, PDT with systemic and particularly with topical agents has become important in treating cutaneous disorders. Topical PDT is indicated for t...
متن کاملPhotodynamic therapy: a review of the literature and image documentation.
Photodynamic therapy (PDT) consists of a chemical reaction activated by light energy that is used to selectively destroy tissue. The reaction requires a photosensitizer in the target tissue, a light source and oxygen. The most extensively studied photosensitizing agents for PDT are 5-aminolevulinic acid for the treatment of actinic keratosis and methyl-aminolevulinate, which has been approved f...
متن کاملTopical photodynamic therapy for prevention of new skin lesions in renal transplant recipients.
Preclinical data suggest that topical methyl aminolevulinate photodynamic therapy may have potential in preventing new skin lesions in transplant recipients. An open intra-patient randomized study investigated the prevention potential of this treatment in 27 renal transplant patients with actinic keratoses and other skin lesions in two circular contralateral areas (5 cm diameter). The treatment...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- Actas dermo-sifiliograficas
دوره 106 1 شماره
صفحات -
تاریخ انتشار 2015